Nisa Investment Advisors LLC Purchases 21,074 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Nisa Investment Advisors LLC grew its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 8.0% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 285,169 shares of the healthcare conglomerate’s stock after buying an additional 21,074 shares during the quarter. UnitedHealth Group accounts for approximately 1.0% of Nisa Investment Advisors LLC’s investment portfolio, making the stock its 11th biggest holding. Nisa Investment Advisors LLC’s holdings in UnitedHealth Group were worth $166,733,000 at the end of the most recent quarter.

Several other hedge funds have also recently modified their holdings of UNH. Woodmont Investment Counsel LLC grew its stake in UnitedHealth Group by 7.2% in the 1st quarter. Woodmont Investment Counsel LLC now owns 20,928 shares of the healthcare conglomerate’s stock valued at $10,353,000 after buying an additional 1,404 shares in the last quarter. Applied Capital LLC FL grew its stake in UnitedHealth Group by 6.2% in the 1st quarter. Applied Capital LLC FL now owns 4,463 shares of the healthcare conglomerate’s stock valued at $2,208,000 after buying an additional 260 shares in the last quarter. Dash Acquisitions Inc. grew its stake in UnitedHealth Group by 4.3% in the 1st quarter. Dash Acquisitions Inc. now owns 650 shares of the healthcare conglomerate’s stock valued at $311,000 after buying an additional 27 shares in the last quarter. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH grew its stake in UnitedHealth Group by 13.8% in the 1st quarter. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH now owns 119,665 shares of the healthcare conglomerate’s stock valued at $59,198,000 after buying an additional 14,489 shares in the last quarter. Finally, Financial Security Advisor Inc. grew its position in shares of UnitedHealth Group by 8.8% during the 1st quarter. Financial Security Advisor Inc. now owns 1,873 shares of the healthcare conglomerate’s stock valued at $926,000 after purchasing an additional 152 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on UNH shares. Barclays reduced their price target on shares of UnitedHealth Group from $604.00 to $603.00 and set an “overweight” rating for the company in a research report on Tuesday, October 22nd. Argus lifted their price objective on shares of UnitedHealth Group from $570.00 to $600.00 and gave the stock a “buy” rating in a report on Wednesday, July 17th. KeyCorp started coverage on shares of UnitedHealth Group in a report on Friday, October 11th. They set an “overweight” rating and a $675.00 price objective for the company. HSBC downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Thursday, October 17th. Finally, Wells Fargo & Company boosted their price target on shares of UnitedHealth Group from $525.00 to $630.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 17th. Four investment analysts have rated the stock with a hold rating, seventeen have given a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $615.53.

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $565.46 on Tuesday. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $608.63. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.88. The company’s 50-day moving average is $583.25 and its 200 day moving average is $539.45. The stock has a market capitalization of $522.16 billion, a P/E ratio of 36.84, a P/E/G ratio of 1.66 and a beta of 0.58.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The company had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. During the same quarter in the previous year, the company earned $6.56 earnings per share. UnitedHealth Group’s quarterly revenue was up 9.2% on a year-over-year basis. On average, sell-side analysts expect that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th were issued a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a yield of 1.49%. The ex-dividend date was Monday, September 16th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 54.72%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.